We are live on
!
Find out more
OI
Oakbrook Investments Portfolio holdings
AUM
$39.2M
1-Year Est. Return
3.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.78%
1 Year Est. Return
-3.66%
3 Year Est. Return
+26.09%
5 Year Est. Return
+53.43%
10 Year Est. Return
–
AUM
$1.8B
AUM Growth
+$220M
(+14%)
Cap. Flow
+$92.2M
Cap. Flow
% of AUM
5.11%
Top 10 Holdings %
Top 10 Hldgs %
23.35%
Holding
698
New
144
Increased
374
Reduced
112
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Colgate-Palmolive
CL
|
+$23M |
| 2 |
Mondelez International
MDLZ
|
+$11.8M |
| 3 |
General Mills
GIS
|
+$11.6M |
| 4 |
Johnson & Johnson
JNJ
|
+$8.36M |
| 5 |
Salesforce
CRM
|
+$5.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$23.4M |
| 2 |
Visa
V
|
+$13.3M |
| 3 |
Autodesk
ADSK
|
+$10.2M |
| 4 |
PepsiCo
PEP
|
+$9.62M |
| 5 |
Oracle
ORCL
|
+$6.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.28% |
| 2 | Healthcare | 15.36% |
| 3 | Financials | 15.12% |
| 4 | Consumer Discretionary | 11.34% |
| 5 | Industrials | 11.17% |
Similar funds
MF
AIM
QCMA
SC
BIM
GP
GAM
SCM
Oakbrook Investments's Q3 2018 Portfolio in Review
As of Q3 2018, Oakbrook Investments held 698 positions worth $1.8B, up 14% from $1.58B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Oakbrook Investments deployed $92.2M of net new capital in Q3 2018, opening 144 new positions and adding to 374 existing holdings. Its largest new stake was Colgate-Palmolive: 345,909 shares worth $23.2M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $23.4M trimmed.
- Oakbrook Investments's largest Q3 2018 buy was Colgate-Palmolive: 345,909 shares worth $23.2M.
- Oakbrook Investments added most to Mondelez International in Q3 2018, an estimated $11.8M increase.
- Oakbrook Investments's biggest Q3 2018 reduction was Gilead Sciences, cutting an estimated $23.4M.
- Oakbrook Investments fully exited CSX Corp in Q3 2018, selling an estimated $3.83M.
- Oakbrook Investments's ten largest holdings make up 23% of its $1.8B portfolio in Q3 2018.
- Oakbrook Investments opened 144 new positions and closed 60 in Q3 2018.
- Oakbrook Investments's portfolio value rose 14% quarter-over-quarter to $1.8B.
Based on Oakbrook Investments's 13F filing for Q3 2018, filed 18 Oct 2018.